Medications for type 2 diabetes
Common hypoglycaemics, mechanisms of action, side effects, practical aspects
The presentation covers:
- Evidence for when to commence medication for type 2 diabetes
- Setting an HbA1c target
- Common hypoglycaemics, mechanisms of action, side effects, practical aspects
- Biguanides
- Sulphonylureas
- α-Glucosidase inhibitors
- DPP-4 inhibitors
- GLP-1 agonists
- SGLT-2 inhibitors
- Insulins commonly used in type 2 diabetes
You can read a review of the presentation here
Watching this presentation and completing the assessment can contribute towards assessable Continuing Professional Development hours
About the Presenter
Dr Nicole Kellow is an Advanced Accredited Practising Dietitian (AdvAPD) and Credentialled Diabetes Educator (CDE) with 20 years of clinical experience. She has a research interest in diabetes and the gut microbiota and completed her PhD in 2017 under joint supervision by the Monash University Department of Public Health & Preventive Medicine and the Baker IDI Heart & Diabetes Institute. Her PhD project investigated dietary and lifestyle interventions to reduce Advanced Glycation End-products (AGEs). Nicole is currently a Senior Research Fellow and an NHMRC Early Career Research Fellow in the Monash University Department of Nutrition, Dietetics & Food, where she is investigating the impact of dietary AGEs on infertility.
Registration includes
- Access to a recording of the presentation
- Presentation notes
- Assessment quiz and certificate
- Suggested further reading
Registration types
- On demand recording: from $38 receive a recording and associated documents
- Subscription: $33 monthly for all Education in Nutrition recordings
- More information on pricing and packages